Skip to main content

Ferrlecit Side Effects

Generic name: sodium ferric gluconate complex

Medically reviewed by Drugs.com. Last updated on Jul 7, 2023.

Note: This document contains side effect information about sodium ferric gluconate complex. Some dosage forms listed on this page may not apply to the brand name Ferrlecit.

Applies to sodium ferric gluconate complex: intravenous solution.

Serious side effects of Ferrlecit

Along with its needed effects, sodium ferric gluconate complex (the active ingredient contained in Ferrlecit) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking sodium ferric gluconate complex:

More common

Incidence not known

Other side effects of Ferrlecit

Some side effects of sodium ferric gluconate complex may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Incidence not known

For Healthcare Professionals

Applies to sodium ferric gluconate complex: intravenous solution.

General

The most common adverse events were nausea, vomiting, diarrhea, injection site reaction, hypotension, cramps, hypertension, dizziness, abnormal erythrocytes (changes in morphology, color, or number of red blood cells), dyspnea, chest pain, leg cramps, pain, headache, and tachycardia.[Ref]

Cardiovascular

Very common (10% or more): Hypotension (35%), hypertension (23%), tachycardia (17%)

Common (1% to 10%): Thrombosis

Frequency not reported: Bradycardia, vasodilatation, angina pectoris, myocardial infarction

Postmarketing reports: Hemorrhage, shock, phlebitis[Ref]

Gastrointestinal

Very common (10% or more): Nausea/vomiting and/or diarrhea (35%)

Common (1% to 10%): Abdominal pain

Frequency not reported: Rectal disorder, dyspepsia, eructation, flatulence, gastrointestinal disorder, melena

Postmarketing reports: Dry mouth[Ref]

Local

Very common (10% or more): Injection site reaction (33%)[Ref]

Hypersensitivity

Postmarketing reports: Allergic reaction, anaphylactic-type reactions[Ref]

Nervous system

Very common (10% or more): Headache (24%), dizziness (13%)

Common (1% to 10%): Headache, paresthesias, syncope

Frequency not reported: Lightheadedness, somnolence, decreased level of consciousness

Postmarketing reports: Hypertonia, loss of consciousness, convulsion, dysgeusia, hypoesthesia[Ref]

Musculoskeletal

Very common (10% or more): Cramps (25%), leg cramps (10%)

Frequency not reported: Myalgia, arthralgia, back pain, arm pain[Ref]

Respiratory

Very common (10% or more): Dyspnea (11%)

Common (1% to 10%): Coughing, upper respiratory infections, pharyngitis, rhinitis

Frequency not reported: Pneumonia, pulmonary edema[Ref]

Dermatologic

Common (1% to 10%): Pruritus

Frequency not reported: Rash, increased sweating

Postmarketing reports: Skin discoloration[Ref]

Hematologic

Very common (10% or more): Abnormal erythrocytes (changes in morphology, color, or number of red blood cells) (11%)

Frequency not reported: Anemia, leukocytosis, lymphadenopathy[Ref]

Other

Very common (10% or more): Chest pain (10%), pain (10%)

Common (1% to 10%): Asthenia, fatigue, fever, malaise, infection, generalized edema

Frequency not reported: Infection, abscess, chills, rigors, flu-like syndrome, weakness, deafness, leg edema, peripheral edema, edema[Ref]

Metabolic

Common (1% to 10%): Hyperkalemia

Frequency not reported: Anorexia, hypoglycemia, hypervolemia, hypokalemia[Ref]

Immunologic

Common (1% to 10%): Infection

Frequency not reported: Sepsis[Ref]

Genitourinary

Frequency not reported: Urinary tract infection, menorrhagia[Ref]

Psychiatric

Frequency not reported: Agitation

Postmarketing reports: Nervousness[Ref]

Oncologic

Frequency not reported: Carcinoma[Ref]

Ocular

Frequency not reported: Conjunctivitis, rolling of the eyes, watery eyes, puffy eye lids, arcus senilis, diplopia[Ref]

References

1. Product Information. Ferrlecit (sodium ferric gluconate complex). sanofi-aventis. 2001;PROD.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.